nodes	percent_of_prediction	percent_of_DWPC	metapath
Pancuronium—CHRNA2—epilepsy syndrome	0.323	0.471	CbGaD
Pancuronium—CHRM3—epilepsy syndrome	0.151	0.221	CbGaD
Pancuronium—CHRM2—epilepsy syndrome	0.115	0.168	CbGaD
Pancuronium—BCHE—epilepsy syndrome	0.0962	0.14	CbGaD
Pancuronium—Respiratory insufficiency—Clobazam—epilepsy syndrome	0.00466	0.0355	CcSEcCtD
Pancuronium—Respiratory insufficiency—Midazolam—epilepsy syndrome	0.00378	0.0287	CcSEcCtD
Pancuronium—CHRNA1—tongue—epilepsy syndrome	0.00351	0.13	CbGeAlD
Pancuronium—Respiratory insufficiency—Felbamate—epilepsy syndrome	0.00334	0.0254	CcSEcCtD
Pancuronium—Salivation—Midazolam—epilepsy syndrome	0.00294	0.0224	CcSEcCtD
Pancuronium—Salivation—Diazepam—epilepsy syndrome	0.00269	0.0205	CcSEcCtD
Pancuronium—Apnoea—Amobarbital—epilepsy syndrome	0.00247	0.0188	CcSEcCtD
Pancuronium—Respiratory failure—Amobarbital—epilepsy syndrome	0.00214	0.0162	CcSEcCtD
Pancuronium—Apnoea—Phenobarbital—epilepsy syndrome	0.00186	0.0141	CcSEcCtD
Pancuronium—Redness—Propofol—epilepsy syndrome	0.00173	0.0131	CcSEcCtD
Pancuronium—SLC22A1—ganglion—epilepsy syndrome	0.00172	0.0638	CbGeAlD
Pancuronium—Redness—Midazolam—epilepsy syndrome	0.00169	0.0129	CcSEcCtD
Pancuronium—Respiratory failure—Phenobarbital—epilepsy syndrome	0.0016	0.0122	CcSEcCtD
Pancuronium—Paralysis—Fosphenytoin—epilepsy syndrome	0.00156	0.0119	CcSEcCtD
Pancuronium—Paralysis—Felbamate—epilepsy syndrome	0.00145	0.0111	CcSEcCtD
Pancuronium—Respiratory failure—Clobazam—epilepsy syndrome	0.00143	0.0109	CcSEcCtD
Pancuronium—Apnoea—Propofol—epilepsy syndrome	0.00137	0.0105	CcSEcCtD
Pancuronium—Paralysis—Phenytoin—epilepsy syndrome	0.00136	0.0104	CcSEcCtD
Pancuronium—Paralysis—Oxcarbazepine—epilepsy syndrome	0.00135	0.0103	CcSEcCtD
Pancuronium—Vecuronium—CHRNA2—epilepsy syndrome	0.00135	0.203	CrCbGaD
Pancuronium—Apnoea—Midazolam—epilepsy syndrome	0.00135	0.0102	CcSEcCtD
Pancuronium—Paralysis—Carbamazepine—epilepsy syndrome	0.0013	0.00989	CcSEcCtD
Pancuronium—Apnoea—Fosphenytoin—epilepsy syndrome	0.00128	0.00976	CcSEcCtD
Pancuronium—Pipecuronium—CHRNA2—epilepsy syndrome	0.00127	0.191	CrCbGaD
Pancuronium—Paralysis—Lamotrigine—epilepsy syndrome	0.00126	0.00956	CcSEcCtD
Pancuronium—CHRNA2—forebrain—epilepsy syndrome	0.00124	0.0457	CbGeAlD
Pancuronium—Drug interaction—Levetiracetam—epilepsy syndrome	0.00121	0.00924	CcSEcCtD
Pancuronium—Rocuronium—CHRNA2—epilepsy syndrome	0.0012	0.181	CrCbGaD
Pancuronium—Respiratory failure—Propofol—epilepsy syndrome	0.00119	0.00903	CcSEcCtD
Pancuronium—Apnoea—Zonisamide—epilepsy syndrome	0.00117	0.00887	CcSEcCtD
Pancuronium—Respiratory failure—Midazolam—epilepsy syndrome	0.00116	0.00884	CcSEcCtD
Pancuronium—Respiratory failure—Levetiracetam—epilepsy syndrome	0.00115	0.00873	CcSEcCtD
Pancuronium—Salivary hypersecretion—Propofol—epilepsy syndrome	0.00113	0.00861	CcSEcCtD
Pancuronium—Apnoea—Phenytoin—epilepsy syndrome	0.00112	0.00849	CcSEcCtD
Pancuronium—Salivary hypersecretion—Midazolam—epilepsy syndrome	0.00111	0.00843	CcSEcCtD
Pancuronium—Drug interaction—Felbamate—epilepsy syndrome	0.00109	0.00828	CcSEcCtD
Pancuronium—Respiratory failure—Vigabatrin—epilepsy syndrome	0.00108	0.00821	CcSEcCtD
Pancuronium—Respiratory failure—Diazepam—epilepsy syndrome	0.00106	0.00808	CcSEcCtD
Pancuronium—Salivary hypersecretion—Fosphenytoin—epilepsy syndrome	0.00106	0.00803	CcSEcCtD
Pancuronium—Apnoea—Lamotrigine—epilepsy syndrome	0.00103	0.00783	CcSEcCtD
Pancuronium—Salivary hypersecretion—Vigabatrin—epilepsy syndrome	0.00103	0.00783	CcSEcCtD
Pancuronium—Respiratory failure—Felbamate—epilepsy syndrome	0.00103	0.00782	CcSEcCtD
Pancuronium—Salivary hypersecretion—Diazepam—epilepsy syndrome	0.00101	0.00771	CcSEcCtD
Pancuronium—Drug interaction—Carbamazepine—epilepsy syndrome	0.000973	0.00741	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Acetazolamide—epilepsy syndrome	0.000941	0.00716	CcSEcCtD
Pancuronium—Drug interaction—Lamotrigine—epilepsy syndrome	0.000941	0.00716	CcSEcCtD
Pancuronium—Salivary hypersecretion—Clonazepam—epilepsy syndrome	0.000925	0.00704	CcSEcCtD
Pancuronium—Salivary hypersecretion—Phenytoin—epilepsy syndrome	0.000919	0.00699	CcSEcCtD
Pancuronium—Paralysis—Pregabalin—epilepsy syndrome	0.000902	0.00687	CcSEcCtD
Pancuronium—Muscular weakness—Clobazam—epilepsy syndrome	0.000901	0.00686	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Propofol—epilepsy syndrome	0.000874	0.00665	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Midazolam—epilepsy syndrome	0.000855	0.00651	CcSEcCtD
Pancuronium—CHRNA1—head—epilepsy syndrome	0.000852	0.0315	CbGeAlD
Pancuronium—Salivary hypersecretion—Lamotrigine—epilepsy syndrome	0.000847	0.00645	CcSEcCtD
Pancuronium—CHRNB1—medulla oblongata—epilepsy syndrome	0.00083	0.0307	CbGeAlD
Pancuronium—Paralysis—Gabapentin—epilepsy syndrome	0.000827	0.0063	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Fosphenytoin—epilepsy syndrome	0.000815	0.0062	CcSEcCtD
Pancuronium—Rocuronium—SLCO1A2—epilepsy syndrome	0.000798	0.12	CrCbGaD
Pancuronium—CHRNB1—midbrain—epilepsy syndrome	0.000759	0.0281	CbGeAlD
Pancuronium—Anaphylactoid reaction—Felbamate—epilepsy syndrome	0.000757	0.00576	CcSEcCtD
Pancuronium—Drug interaction—Valproic Acid—epilepsy syndrome	0.000748	0.00569	CcSEcCtD
Pancuronium—CHRNB1—spinal cord—epilepsy syndrome	0.00074	0.0274	CbGeAlD
Pancuronium—Apnoea—Pregabalin—epilepsy syndrome	0.00074	0.00563	CcSEcCtD
Pancuronium—CHRM2—forebrain—epilepsy syndrome	0.000737	0.0272	CbGeAlD
Pancuronium—Muscular weakness—Midazolam—epilepsy syndrome	0.00073	0.00556	CcSEcCtD
Pancuronium—SLC22A1—forebrain—epilepsy syndrome	0.000724	0.0268	CbGeAlD
Pancuronium—Muscular weakness—Levetiracetam—epilepsy syndrome	0.000721	0.00549	CcSEcCtD
Pancuronium—Bronchospasm—Propofol—epilepsy syndrome	0.000719	0.00547	CcSEcCtD
Pancuronium—Redness—Topiramate—epilepsy syndrome	0.000716	0.00545	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Phenytoin—epilepsy syndrome	0.000709	0.0054	CcSEcCtD
Pancuronium—CHRNA2—head—epilepsy syndrome	0.000707	0.0262	CbGeAlD
Pancuronium—Bronchospasm—Midazolam—epilepsy syndrome	0.000704	0.00535	CcSEcCtD
Pancuronium—Hypotension—Amobarbital—epilepsy syndrome	0.000699	0.00532	CcSEcCtD
Pancuronium—Muscular weakness—Fosphenytoin—epilepsy syndrome	0.000696	0.00529	CcSEcCtD
Pancuronium—Erythema—Phenobarbital—epilepsy syndrome	0.000688	0.00524	CcSEcCtD
Pancuronium—Apnoea—Gabapentin—epilepsy syndrome	0.000678	0.00516	CcSEcCtD
Pancuronium—CHRM2—telencephalon—epilepsy syndrome	0.000677	0.025	CbGeAlD
Pancuronium—CHRNA2—nervous system—epilepsy syndrome	0.000671	0.0248	CbGeAlD
Pancuronium—Muscular weakness—Diazepam—epilepsy syndrome	0.000668	0.00508	CcSEcCtD
Pancuronium—SLC22A1—telencephalon—epilepsy syndrome	0.000665	0.0246	CbGeAlD
Pancuronium—CHRNB1—head—epilepsy syndrome	0.000658	0.0243	CbGeAlD
Pancuronium—Muscular weakness—Felbamate—epilepsy syndrome	0.000646	0.00492	CcSEcCtD
Pancuronium—CHRNA2—central nervous system—epilepsy syndrome	0.000646	0.0239	CbGeAlD
Pancuronium—Respiratory failure—Pregabalin—epilepsy syndrome	0.000638	0.00486	CcSEcCtD
Pancuronium—Erythema—Lacosamide—epilepsy syndrome	0.000634	0.00483	CcSEcCtD
Pancuronium—Muscular weakness—Zonisamide—epilepsy syndrome	0.000633	0.00481	CcSEcCtD
Pancuronium—CHRNA2—cerebellum—epilepsy syndrome	0.000631	0.0233	CbGeAlD
Pancuronium—Drug interaction—Gabapentin—epilepsy syndrome	0.00062	0.00472	CcSEcCtD
Pancuronium—CHRNA1—brain—epilepsy syndrome	0.000618	0.0228	CbGeAlD
Pancuronium—Muscular weakness—Clonazepam—epilepsy syndrome	0.00061	0.00464	CcSEcCtD
Pancuronium—Salivary hypersecretion—Pregabalin—epilepsy syndrome	0.000609	0.00463	CcSEcCtD
Pancuronium—Muscular weakness—Phenytoin—epilepsy syndrome	0.000606	0.00461	CcSEcCtD
Pancuronium—Muscular weakness—Oxcarbazepine—epilepsy syndrome	0.000602	0.00458	CcSEcCtD
Pancuronium—CHRM3—forebrain—epilepsy syndrome	0.0006	0.0222	CbGeAlD
Pancuronium—Pipecuronium—CHRM3—epilepsy syndrome	0.000595	0.0897	CrCbGaD
Pancuronium—CHRNB1—cerebellum—epilepsy syndrome	0.000587	0.0217	CbGeAlD
Pancuronium—Respiratory failure—Gabapentin—epilepsy syndrome	0.000585	0.00445	CcSEcCtD
Pancuronium—Flushing—Acetazolamide—epilepsy syndrome	0.000585	0.00445	CcSEcCtD
Pancuronium—Bronchospasm—Oxcarbazepine—epilepsy syndrome	0.000581	0.00442	CcSEcCtD
Pancuronium—Muscular weakness—Carbamazepine—epilepsy syndrome	0.000578	0.0044	CcSEcCtD
Pancuronium—Muscular weakness—Lamotrigine—epilepsy syndrome	0.000559	0.00425	CcSEcCtD
Pancuronium—Salivary hypersecretion—Gabapentin—epilepsy syndrome	0.000558	0.00425	CcSEcCtD
Pancuronium—CHRM3—telencephalon—epilepsy syndrome	0.000552	0.0204	CbGeAlD
Pancuronium—Hypersensitivity—Amobarbital—epilepsy syndrome	0.000551	0.00419	CcSEcCtD
Pancuronium—Flushing—Propofol—epilepsy syndrome	0.000543	0.00413	CcSEcCtD
Pancuronium—Bronchospasm—Lamotrigine—epilepsy syndrome	0.000539	0.0041	CcSEcCtD
Pancuronium—Hypotension—Phenobarbital—epilepsy syndrome	0.000525	0.00399	CcSEcCtD
Pancuronium—Drug interaction—Topiramate—epilepsy syndrome	0.000521	0.00397	CcSEcCtD
Pancuronium—CHRNA2—brain—epilepsy syndrome	0.000513	0.019	CbGeAlD
Pancuronium—Erythema—Propofol—epilepsy syndrome	0.00051	0.00388	CcSEcCtD
Pancuronium—BCHE—brainstem—epilepsy syndrome	0.000507	0.0188	CbGeAlD
Pancuronium—Erythema—Midazolam—epilepsy syndrome	0.000498	0.00379	CcSEcCtD
Pancuronium—BCHE—forebrain—epilepsy syndrome	0.00049	0.0181	CbGeAlD
Pancuronium—CHRNB1—brain—epilepsy syndrome	0.000477	0.0176	CbGeAlD
Pancuronium—Rash—Amobarbital—epilepsy syndrome	0.000472	0.00359	CcSEcCtD
Pancuronium—Dermatitis—Amobarbital—epilepsy syndrome	0.000471	0.00359	CcSEcCtD
Pancuronium—Flushing—Felbamate—epilepsy syndrome	0.00047	0.00358	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Pregabalin—epilepsy syndrome	0.00047	0.00358	CcSEcCtD
Pancuronium—Salivary hypersecretion—Topiramate—epilepsy syndrome	0.00047	0.00357	CcSEcCtD
Pancuronium—Hypotension—Clobazam—epilepsy syndrome	0.000469	0.00357	CcSEcCtD
Pancuronium—Erythema—Diazepam—epilepsy syndrome	0.000456	0.00347	CcSEcCtD
Pancuronium—Rash—Primidone—epilepsy syndrome	0.000454	0.00346	CcSEcCtD
Pancuronium—Dermatitis—Primidone—epilepsy syndrome	0.000454	0.00345	CcSEcCtD
Pancuronium—Pipecuronium—CHRM2—epilepsy syndrome	0.000453	0.0683	CrCbGaD
Pancuronium—BCHE—telencephalon—epilepsy syndrome	0.00045	0.0167	CbGeAlD
Pancuronium—Anaphylactic shock—Acetazolamide—epilepsy syndrome	0.000448	0.00341	CcSEcCtD
Pancuronium—Muscular weakness—Valproic Acid—epilepsy syndrome	0.000444	0.00338	CcSEcCtD
Pancuronium—Flushing—Clonazepam—epilepsy syndrome	0.000444	0.00338	CcSEcCtD
Pancuronium—Flushing—Oxcarbazepine—epilepsy syndrome	0.000439	0.00334	CcSEcCtD
Pancuronium—Rocuronium—CHRM2—epilepsy syndrome	0.00043	0.0648	CrCbGaD
Pancuronium—CHRM2—head—epilepsy syndrome	0.000422	0.0156	CbGeAlD
Pancuronium—Flushing—Carbamazepine—epilepsy syndrome	0.000421	0.0032	CcSEcCtD
Pancuronium—Anaphylactic shock—Propofol—epilepsy syndrome	0.000416	0.00316	CcSEcCtD
Pancuronium—SLC22A1—head—epilepsy syndrome	0.000414	0.0153	CbGeAlD
Pancuronium—Hypersensitivity—Phenobarbital—epilepsy syndrome	0.000414	0.00315	CcSEcCtD
Pancuronium—Anaphylactic shock—Midazolam—epilepsy syndrome	0.000407	0.0031	CcSEcCtD
Pancuronium—Flushing—Lamotrigine—epilepsy syndrome	0.000407	0.00309	CcSEcCtD
Pancuronium—Hypersensitivity—Rufinamide—epilepsy syndrome	0.000406	0.00309	CcSEcCtD
Pancuronium—Tachycardia—Propofol—epilepsy syndrome	0.000406	0.00309	CcSEcCtD
Pancuronium—Muscular weakness—Pregabalin—epilepsy syndrome	0.000401	0.00305	CcSEcCtD
Pancuronium—CHRM2—nervous system—epilepsy syndrome	0.0004	0.0148	CbGeAlD
Pancuronium—Rash—Trimethadione—epilepsy syndrome	0.0004	0.00304	CcSEcCtD
Pancuronium—Dermatitis—Trimethadione—epilepsy syndrome	0.000399	0.00304	CcSEcCtD
Pancuronium—Tachycardia—Midazolam—epilepsy syndrome	0.000397	0.00302	CcSEcCtD
Pancuronium—Erythema—Carbamazepine—epilepsy syndrome	0.000395	0.003	CcSEcCtD
Pancuronium—SLC22A1—nervous system—epilepsy syndrome	0.000393	0.0145	CbGeAlD
Pancuronium—Hypotension—Propofol—epilepsy syndrome	0.000389	0.00296	CcSEcCtD
Pancuronium—Anaphylactic shock—Fosphenytoin—epilepsy syndrome	0.000388	0.00295	CcSEcCtD
Pancuronium—CHRM2—central nervous system—epilepsy syndrome	0.000385	0.0142	CbGeAlD
Pancuronium—Erythema—Lamotrigine—epilepsy syndrome	0.000381	0.0029	CcSEcCtD
Pancuronium—Hypersensitivity—Lacosamide—epilepsy syndrome	0.000381	0.0029	CcSEcCtD
Pancuronium—Hypotension—Midazolam—epilepsy syndrome	0.00038	0.00289	CcSEcCtD
Pancuronium—Tachycardia—Fosphenytoin—epilepsy syndrome	0.000378	0.00288	CcSEcCtD
Pancuronium—SLC22A1—central nervous system—epilepsy syndrome	0.000378	0.014	CbGeAlD
Pancuronium—Pipecuronium—BCHE—epilepsy syndrome	0.000378	0.057	CrCbGaD
Pancuronium—Anaphylactic shock—Diazepam—epilepsy syndrome	0.000372	0.00283	CcSEcCtD
Pancuronium—Muscular weakness—Gabapentin—epilepsy syndrome	0.000368	0.0028	CcSEcCtD
Pancuronium—Tachycardia—Diazepam—epilepsy syndrome	0.000363	0.00276	CcSEcCtD
Pancuronium—Hypotension—Fosphenytoin—epilepsy syndrome	0.000362	0.00276	CcSEcCtD
Pancuronium—Anaphylactic shock—Felbamate—epilepsy syndrome	0.00036	0.00274	CcSEcCtD
Pancuronium—Bronchospasm—Gabapentin—epilepsy syndrome	0.000355	0.0027	CcSEcCtD
Pancuronium—Rash—Phenobarbital—epilepsy syndrome	0.000354	0.00269	CcSEcCtD
Pancuronium—BCHE—medulla oblongata—epilepsy syndrome	0.000354	0.0131	CbGeAlD
Pancuronium—Dermatitis—Phenobarbital—epilepsy syndrome	0.000354	0.00269	CcSEcCtD
Pancuronium—Tachycardia—Felbamate—epilepsy syndrome	0.000351	0.00267	CcSEcCtD
Pancuronium—Hypotension—Diazepam—epilepsy syndrome	0.000348	0.00265	CcSEcCtD
Pancuronium—Rash—Rufinamide—epilepsy syndrome	0.000348	0.00264	CcSEcCtD
Pancuronium—Dermatitis—Rufinamide—epilepsy syndrome	0.000347	0.00264	CcSEcCtD
Pancuronium—Tachycardia—Zonisamide—epilepsy syndrome	0.000344	0.00262	CcSEcCtD
Pancuronium—CHRM3—head—epilepsy syndrome	0.000344	0.0127	CbGeAlD
Pancuronium—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.00034	0.00259	CcSEcCtD
Pancuronium—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.000337	0.00257	CcSEcCtD
Pancuronium—Hypotension—Felbamate—epilepsy syndrome	0.000337	0.00256	CcSEcCtD
Pancuronium—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.000336	0.00255	CcSEcCtD
Pancuronium—Tachycardia—Clonazepam—epilepsy syndrome	0.000332	0.00252	CcSEcCtD
Pancuronium—Hypotension—Zonisamide—epilepsy syndrome	0.000329	0.00251	CcSEcCtD
Pancuronium—Tachycardia—Phenytoin—epilepsy syndrome	0.000329	0.00251	CcSEcCtD
Pancuronium—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000328	0.00249	CcSEcCtD
Pancuronium—Rash—Lacosamide—epilepsy syndrome	0.000326	0.00248	CcSEcCtD
Pancuronium—Dermatitis—Lacosamide—epilepsy syndrome	0.000326	0.00248	CcSEcCtD
Pancuronium—CHRM3—nervous system—epilepsy syndrome	0.000326	0.012	CbGeAlD
Pancuronium—BCHE—midbrain—epilepsy syndrome	0.000323	0.012	CbGeAlD
Pancuronium—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.000322	0.00245	CcSEcCtD
Pancuronium—Hypotension—Clonazepam—epilepsy syndrome	0.000317	0.00242	CcSEcCtD
Pancuronium—Rash—Clobazam—epilepsy syndrome	0.000317	0.00241	CcSEcCtD
Pancuronium—Dermatitis—Clobazam—epilepsy syndrome	0.000316	0.00241	CcSEcCtD
Pancuronium—BCHE—spinal cord—epilepsy syndrome	0.000316	0.0117	CbGeAlD
Pancuronium—Hypotension—Phenytoin—epilepsy syndrome	0.000315	0.0024	CcSEcCtD
Pancuronium—Tachycardia—Carbamazepine—epilepsy syndrome	0.000314	0.00239	CcSEcCtD
Pancuronium—Hypotension—Oxcarbazepine—epilepsy syndrome	0.000314	0.00239	CcSEcCtD
Pancuronium—CHRM3—central nervous system—epilepsy syndrome	0.000314	0.0116	CbGeAlD
Pancuronium—Muscular weakness—Topiramate—epilepsy syndrome	0.00031	0.00236	CcSEcCtD
Pancuronium—CHRM2—brain—epilepsy syndrome	0.000306	0.0113	CbGeAlD
Pancuronium—Tachycardia—Lamotrigine—epilepsy syndrome	0.000304	0.00231	CcSEcCtD
Pancuronium—Hypotension—Carbamazepine—epilepsy syndrome	0.000301	0.00229	CcSEcCtD
Pancuronium—SLC22A1—brain—epilepsy syndrome	0.0003	0.0111	CbGeAlD
Pancuronium—Hypersensitivity—Midazolam—epilepsy syndrome	0.0003	0.00228	CcSEcCtD
Pancuronium—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000296	0.00225	CcSEcCtD
Pancuronium—Flushing—Pregabalin—epilepsy syndrome	0.000292	0.00222	CcSEcCtD
Pancuronium—BCHE—head—epilepsy syndrome	0.00028	0.0104	CbGeAlD
Pancuronium—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000278	0.00212	CcSEcCtD
Pancuronium—Hypersensitivity—Diazepam—epilepsy syndrome	0.000274	0.00209	CcSEcCtD
Pancuronium—BCHE—nervous system—epilepsy syndrome	0.000266	0.00983	CbGeAlD
Pancuronium—Rash—Propofol—epilepsy syndrome	0.000262	0.002	CcSEcCtD
Pancuronium—Dermatitis—Propofol—epilepsy syndrome	0.000262	0.00199	CcSEcCtD
Pancuronium—Hypersensitivity—Zonisamide—epilepsy syndrome	0.00026	0.00198	CcSEcCtD
Pancuronium—Rash—Midazolam—epilepsy syndrome	0.000257	0.00195	CcSEcCtD
Pancuronium—Dermatitis—Midazolam—epilepsy syndrome	0.000256	0.00195	CcSEcCtD
Pancuronium—BCHE—central nervous system—epilepsy syndrome	0.000256	0.00947	CbGeAlD
Pancuronium—Rash—Levetiracetam—epilepsy syndrome	0.000253	0.00193	CcSEcCtD
Pancuronium—Dermatitis—Levetiracetam—epilepsy syndrome	0.000253	0.00193	CcSEcCtD
Pancuronium—Erythema—Gabapentin—epilepsy syndrome	0.000251	0.00191	CcSEcCtD
Pancuronium—Hypersensitivity—Clonazepam—epilepsy syndrome	0.00025	0.0019	CcSEcCtD
Pancuronium—BCHE—cerebellum—epilepsy syndrome	0.00025	0.00925	CbGeAlD
Pancuronium—CHRM3—brain—epilepsy syndrome	0.000249	0.00921	CbGeAlD
Pancuronium—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000249	0.00189	CcSEcCtD
Pancuronium—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000247	0.00188	CcSEcCtD
Pancuronium—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000247	0.00188	CcSEcCtD
Pancuronium—Rash—Fosphenytoin—epilepsy syndrome	0.000244	0.00186	CcSEcCtD
Pancuronium—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000244	0.00186	CcSEcCtD
Pancuronium—Tachycardia—Valproic Acid—epilepsy syndrome	0.000241	0.00184	CcSEcCtD
Pancuronium—Rash—Vigabatrin—epilepsy syndrome	0.000238	0.00181	CcSEcCtD
Pancuronium—Dermatitis—Vigabatrin—epilepsy syndrome	0.000238	0.00181	CcSEcCtD
Pancuronium—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000237	0.00181	CcSEcCtD
Pancuronium—Rash—Diazepam—epilepsy syndrome	0.000235	0.00179	CcSEcCtD
Pancuronium—Dermatitis—Diazepam—epilepsy syndrome	0.000234	0.00178	CcSEcCtD
Pancuronium—Hypotension—Valproic Acid—epilepsy syndrome	0.000231	0.00176	CcSEcCtD
Pancuronium—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000229	0.00175	CcSEcCtD
Pancuronium—Rash—Felbamate—epilepsy syndrome	0.000227	0.00173	CcSEcCtD
Pancuronium—Dermatitis—Felbamate—epilepsy syndrome	0.000227	0.00173	CcSEcCtD
Pancuronium—Flushing—Topiramate—epilepsy syndrome	0.000225	0.00172	CcSEcCtD
Pancuronium—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000224	0.0017	CcSEcCtD
Pancuronium—Rash—Zonisamide—epilepsy syndrome	0.000222	0.00169	CcSEcCtD
Pancuronium—Dermatitis—Zonisamide—epilepsy syndrome	0.000222	0.00169	CcSEcCtD
Pancuronium—Tachycardia—Pregabalin—epilepsy syndrome	0.000218	0.00166	CcSEcCtD
Pancuronium—Rash—Clonazepam—epilepsy syndrome	0.000214	0.00163	CcSEcCtD
Pancuronium—Dermatitis—Clonazepam—epilepsy syndrome	0.000214	0.00163	CcSEcCtD
Pancuronium—Rash—Phenytoin—epilepsy syndrome	0.000213	0.00162	CcSEcCtD
Pancuronium—Dermatitis—Phenytoin—epilepsy syndrome	0.000213	0.00162	CcSEcCtD
Pancuronium—Rash—Oxcarbazepine—epilepsy syndrome	0.000212	0.00161	CcSEcCtD
Pancuronium—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000211	0.00161	CcSEcCtD
Pancuronium—Erythema—Topiramate—epilepsy syndrome	0.000211	0.00161	CcSEcCtD
Pancuronium—Hypotension—Pregabalin—epilepsy syndrome	0.000209	0.00159	CcSEcCtD
Pancuronium—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000205	0.00156	CcSEcCtD
Pancuronium—BCHE—brain—epilepsy syndrome	0.000203	0.00751	CbGeAlD
Pancuronium—Rash—Carbamazepine—epilepsy syndrome	0.000203	0.00155	CcSEcCtD
Pancuronium—Dermatitis—Carbamazepine—epilepsy syndrome	0.000203	0.00154	CcSEcCtD
Pancuronium—Tachycardia—Gabapentin—epilepsy syndrome	0.0002	0.00152	CcSEcCtD
Pancuronium—Rash—Lamotrigine—epilepsy syndrome	0.000196	0.00149	CcSEcCtD
Pancuronium—Dermatitis—Lamotrigine—epilepsy syndrome	0.000196	0.00149	CcSEcCtD
Pancuronium—Hypotension—Gabapentin—epilepsy syndrome	0.000192	0.00146	CcSEcCtD
Pancuronium—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000182	0.00139	CcSEcCtD
Pancuronium—Tachycardia—Topiramate—epilepsy syndrome	0.000168	0.00128	CcSEcCtD
Pancuronium—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000165	0.00125	CcSEcCtD
Pancuronium—Hypotension—Topiramate—epilepsy syndrome	0.000161	0.00123	CcSEcCtD
Pancuronium—Vecuronium—ABCB1—epilepsy syndrome	0.000158	0.0238	CrCbGaD
Pancuronium—Rash—Valproic Acid—epilepsy syndrome	0.000156	0.00119	CcSEcCtD
Pancuronium—Dermatitis—Valproic Acid—epilepsy syndrome	0.000156	0.00119	CcSEcCtD
Pancuronium—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000151	0.00115	CcSEcCtD
Pancuronium—Rash—Pregabalin—epilepsy syndrome	0.000141	0.00107	CcSEcCtD
Pancuronium—Dermatitis—Pregabalin—epilepsy syndrome	0.000141	0.00107	CcSEcCtD
Pancuronium—Rash—Gabapentin—epilepsy syndrome	0.000129	0.000984	CcSEcCtD
Pancuronium—Dermatitis—Gabapentin—epilepsy syndrome	0.000129	0.000983	CcSEcCtD
Pancuronium—Hypersensitivity—Topiramate—epilepsy syndrome	0.000127	0.000967	CcSEcCtD
Pancuronium—Rash—Topiramate—epilepsy syndrome	0.000109	0.000828	CcSEcCtD
Pancuronium—Dermatitis—Topiramate—epilepsy syndrome	0.000109	0.000827	CcSEcCtD
Pancuronium—CHRM2—Signaling by GPCR—PLCB1—epilepsy syndrome	7.16e-06	4.8e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—GRM1—epilepsy syndrome	7.14e-06	4.79e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PDYN—epilepsy syndrome	7.14e-06	4.79e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CCR7—epilepsy syndrome	7.14e-06	4.79e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CHRM1—epilepsy syndrome	7.14e-06	4.79e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—HTR7—epilepsy syndrome	7.08e-06	4.75e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ABCG2—epilepsy syndrome	7.07e-06	4.75e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—ADRA2A—epilepsy syndrome	7.07e-06	4.74e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of proteins—POMC—epilepsy syndrome	7.06e-06	4.74e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—HTR7—epilepsy syndrome	7.01e-06	4.7e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of proteins—CCL2—epilepsy syndrome	6.9e-06	4.63e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—CYP2C19—epilepsy syndrome	6.89e-06	4.62e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—HBEGF—epilepsy syndrome	6.87e-06	4.61e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—CYP11A1—epilepsy syndrome	6.85e-06	4.6e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—HBEGF—epilepsy syndrome	6.8e-06	4.57e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—CDC42—epilepsy syndrome	6.78e-06	4.55e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—GAL—epilepsy syndrome	6.77e-06	4.55e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—GFAP—epilepsy syndrome	6.77e-06	4.55e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—AKT3—epilepsy syndrome	6.74e-06	4.53e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—SLC2A1—epilepsy syndrome	6.71e-06	4.51e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—CDC42—epilepsy syndrome	6.71e-06	4.5e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—GAL—epilepsy syndrome	6.71e-06	4.5e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—GFAP—epilepsy syndrome	6.71e-06	4.5e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—GRM5—epilepsy syndrome	6.7e-06	4.5e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CASP2—epilepsy syndrome	6.7e-06	4.5e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—AKT3—epilepsy syndrome	6.68e-06	4.48e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PLCB1—epilepsy syndrome	6.64e-06	4.46e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CASP2—epilepsy syndrome	6.63e-06	4.45e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—GRM5—epilepsy syndrome	6.63e-06	4.45e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CHRM3—epilepsy syndrome	6.63e-06	4.45e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—CYP2D6—epilepsy syndrome	6.63e-06	4.45e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—TH—epilepsy syndrome	6.62e-06	4.44e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—AVP—epilepsy syndrome	6.56e-06	4.4e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ABCG2—epilepsy syndrome	6.53e-06	4.38e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.51e-06	4.37e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—AVP—epilepsy syndrome	6.5e-06	4.36e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CX3CR1—epilepsy syndrome	6.42e-06	4.31e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CYP2C19—epilepsy syndrome	6.36e-06	4.27e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CX3CR1—epilepsy syndrome	6.36e-06	4.27e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CYP11A1—epilepsy syndrome	6.33e-06	4.25e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	6.32e-06	4.24e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—ADRA2A—epilepsy syndrome	6.31e-06	4.24e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CHRM2—epilepsy syndrome	6.3e-06	4.23e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CX3CL1—epilepsy syndrome	6.3e-06	4.23e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—BDKRB1—epilepsy syndrome	6.3e-06	4.23e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—BCHE—epilepsy syndrome	6.29e-06	4.22e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CX3CL1—epilepsy syndrome	6.24e-06	4.19e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—BDKRB1—epilepsy syndrome	6.24e-06	4.19e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—CYP2D6—epilepsy syndrome	6.18e-06	4.15e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—CDC42—epilepsy syndrome	6.15e-06	4.13e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—GABBR1—epilepsy syndrome	6.13e-06	4.11e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—CDC42—epilepsy syndrome	6.09e-06	4.09e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—GABBR1—epilepsy syndrome	6.07e-06	4.07e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—SLC2A1—epilepsy syndrome	6e-06	4.02e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—AVP—epilepsy syndrome	5.96e-06	4e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PLCB1—epilepsy syndrome	5.93e-06	3.98e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—TH—epilepsy syndrome	5.91e-06	3.97e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—AVP—epilepsy syndrome	5.9e-06	3.96e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.89e-06	3.96e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ADRA2A—epilepsy syndrome	5.88e-06	3.95e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HRH3—epilepsy syndrome	5.87e-06	3.94e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—BCHE—epilepsy syndrome	5.86e-06	3.93e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HRH3—epilepsy syndrome	5.82e-06	3.9e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—OPRM1—epilepsy syndrome	5.78e-06	3.88e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—OPRM1—epilepsy syndrome	5.73e-06	3.84e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CYP2D6—epilepsy syndrome	5.71e-06	3.83e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—SLC2A1—epilepsy syndrome	5.59e-06	3.75e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—CCR5—epilepsy syndrome	5.58e-06	3.74e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PLCB1—epilepsy syndrome	5.53e-06	3.71e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—CCR5—epilepsy syndrome	5.52e-06	3.71e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—HMOX1—epilepsy syndrome	5.52e-06	3.71e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—TH—epilepsy syndrome	5.51e-06	3.7e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CCR3—epilepsy syndrome	5.46e-06	3.67e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—HTR2A—epilepsy syndrome	5.46e-06	3.66e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—CAT—epilepsy syndrome	5.45e-06	3.66e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ADRA2A—epilepsy syndrome	5.43e-06	3.65e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—BCHE—epilepsy syndrome	5.41e-06	3.63e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CCR3—epilepsy syndrome	5.41e-06	3.63e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—HTR2A—epilepsy syndrome	5.41e-06	3.63e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NPY—epilepsy syndrome	5.32e-06	3.57e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ATP2A2—epilepsy syndrome	5.32e-06	3.57e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—ABCB1—epilepsy syndrome	5.3e-06	3.56e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NPY—epilepsy syndrome	5.27e-06	3.54e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ATP2A2—epilepsy syndrome	5.27e-06	3.54e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—AGT—epilepsy syndrome	5.18e-06	3.48e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—SLC2A1—epilepsy syndrome	5.16e-06	3.46e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CRH—epilepsy syndrome	5.13e-06	3.45e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—OXT—epilepsy syndrome	5.13e-06	3.45e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HSPB1—epilepsy syndrome	5.13e-06	3.45e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CXCL2—epilepsy syndrome	5.13e-06	3.45e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CCL3—epilepsy syndrome	5.13e-06	3.45e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—AGT—epilepsy syndrome	5.13e-06	3.44e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PLCB1—epilepsy syndrome	5.11e-06	3.43e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—TH—epilepsy syndrome	5.09e-06	3.41e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	5.08e-06	3.41e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	5.08e-06	3.41e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	5.08e-06	3.41e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	5.08e-06	3.41e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	5.08e-06	3.41e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—CCR5—epilepsy syndrome	5.07e-06	3.4e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	5.02e-06	3.37e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—HTR2A—epilepsy syndrome	4.96e-06	3.33e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—HMOX1—epilepsy syndrome	4.93e-06	3.31e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—GPX1—epilepsy syndrome	4.93e-06	3.31e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	4.91e-06	3.29e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—CAT—epilepsy syndrome	4.87e-06	3.27e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	4.79e-06	3.21e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	4.77e-06	3.2e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	4.77e-06	3.2e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	4.74e-06	3.18e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—ABCB1—epilepsy syndrome	4.73e-06	3.18e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	4.73e-06	3.17e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	4.73e-06	3.17e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	4.7e-06	3.16e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	4.66e-06	3.13e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—SST—epilepsy syndrome	4.64e-06	3.12e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	4.64e-06	3.12e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	4.64e-06	3.12e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	4.6e-06	3.09e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	4.6e-06	3.09e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	4.6e-06	3.09e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—SST—epilepsy syndrome	4.6e-06	3.09e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—HMOX1—epilepsy syndrome	4.6e-06	3.09e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	4.56e-06	3.06e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	4.54e-06	3.05e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—CAT—epilepsy syndrome	4.54e-06	3.04e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	4.53e-06	3.04e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	4.5e-06	3.02e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	4.48e-06	3.01e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ABCB1—epilepsy syndrome	4.41e-06	2.96e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—GPX1—epilepsy syndrome	4.4e-06	2.95e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	4.37e-06	2.93e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	4.37e-06	2.93e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	4.36e-06	2.93e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	4.35e-06	2.92e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	4.33e-06	2.9e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	4.32e-06	2.9e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	4.32e-06	2.9e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—AGT—epilepsy syndrome	4.32e-06	2.9e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	4.32e-06	2.9e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	4.3e-06	2.89e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	4.29e-06	2.88e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	4.29e-06	2.88e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	4.29e-06	2.88e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	4.27e-06	2.87e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—HMOX1—epilepsy syndrome	4.25e-06	2.85e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	4.24e-06	2.85e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	4.24e-06	2.85e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—APOE—epilepsy syndrome	4.23e-06	2.84e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	4.23e-06	2.84e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CAT—epilepsy syndrome	4.19e-06	2.81e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	4.18e-06	2.81e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	4.14e-06	2.78e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—GPX1—epilepsy syndrome	4.1e-06	2.75e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ABCB1—epilepsy syndrome	4.08e-06	2.74e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	4.06e-06	2.72e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	4.02e-06	2.7e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	3.98e-06	2.67e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	3.96e-06	2.66e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	3.95e-06	2.65e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	3.92e-06	2.63e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	3.89e-06	2.61e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	3.87e-06	2.6e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—AGT—epilepsy syndrome	3.86e-06	2.59e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	3.85e-06	2.59e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	3.84e-06	2.57e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—GPX1—epilepsy syndrome	3.79e-06	2.54e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—APOE—epilepsy syndrome	3.78e-06	2.54e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	3.68e-06	2.47e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	3.64e-06	2.45e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	3.64e-06	2.45e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—POMC—epilepsy syndrome	3.64e-06	2.44e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	3.63e-06	2.44e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	3.61e-06	2.42e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	3.6e-06	2.42e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—AGT—epilepsy syndrome	3.6e-06	2.41e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—APOE—epilepsy syndrome	3.52e-06	2.37e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	3.52e-06	2.36e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	3.48e-06	2.34e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	3.33e-06	2.23e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—AGT—epilepsy syndrome	3.32e-06	2.23e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—ALB—epilepsy syndrome	3.32e-06	2.23e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	3.3e-06	2.21e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—APOE—epilepsy syndrome	3.26e-06	2.18e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—POMC—epilepsy syndrome	3.25e-06	2.18e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	3.24e-06	2.17e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	3.22e-06	2.16e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	3.22e-06	2.16e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	3.2e-06	2.15e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	3.19e-06	2.14e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	3.19e-06	2.14e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	3.11e-06	2.09e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	3.08e-06	2.07e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	3.08e-06	2.06e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	3.05e-06	2.04e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—POMC—epilepsy syndrome	3.03e-06	2.03e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	2.99e-06	2.01e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	2.96e-06	1.99e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—ALB—epilepsy syndrome	2.96e-06	1.99e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	2.93e-06	1.97e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PTGS2—epilepsy syndrome	2.9e-06	1.95e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	2.9e-06	1.95e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—POMC—epilepsy syndrome	2.8e-06	1.88e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	2.78e-06	1.87e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	2.78e-06	1.86e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ALB—epilepsy syndrome	2.76e-06	1.85e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	2.75e-06	1.85e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	2.75e-06	1.85e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	2.72e-06	1.83e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	2.7e-06	1.81e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	2.67e-06	1.79e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	2.64e-06	1.77e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PTGS2—epilepsy syndrome	2.59e-06	1.74e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	2.57e-06	1.72e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	2.56e-06	1.72e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ALB—epilepsy syndrome	2.55e-06	1.71e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	2.54e-06	1.71e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	2.53e-06	1.7e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PTGS2—epilepsy syndrome	2.41e-06	1.62e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	2.34e-06	1.57e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	2.32e-06	1.55e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	2.29e-06	1.54e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	2.27e-06	1.52e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PTGS2—epilepsy syndrome	2.23e-06	1.5e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	2.07e-06	1.39e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	2.05e-06	1.37e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	1.92e-06	1.29e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	1.9e-06	1.28e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	1.88e-06	1.26e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	1.86e-06	1.25e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	1.75e-06	1.17e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	1.73e-06	1.16e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.73e-06	1.16e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	1.71e-06	1.15e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	1.68e-06	1.13e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	1.67e-06	1.12e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	1.64e-06	1.1e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	1.62e-06	1.09e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	1.59e-06	1.07e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	1.57e-06	1.05e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	1.51e-06	1.01e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	1.49e-06	1e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	1.47e-06	9.86e-06	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—AKT1—epilepsy syndrome	1.46e-06	9.79e-06	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	1.45e-06	9.77e-06	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—AKT1—epilepsy syndrome	1.3e-06	8.74e-06	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—AKT1—epilepsy syndrome	1.21e-06	8.15e-06	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—AKT1—epilepsy syndrome	1.12e-06	7.52e-06	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	9.37e-07	6.29e-06	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	9.28e-07	6.23e-06	CbGpPWpGaD
